Syros Pharmaceuticals, Inc. (SYRS) Operating Margin

Official company branding of Syros Pharmaceuticals (SYRS)

Syros Pharmaceuticals (SYRS) innovative approach to reprogramming cancer cells correlates with the fact that operational efficiency dynamics on GURU.Markets contain the value 0.00. The company is currently restructuring its debt and seeking buyers for its patents following unsuccessful tests. However, future share price growth depends on the results of the Phase 3 clinical trials for tamibarotene and FDA approval.

SYRS - Syros Pharmaceuticals Inc. Operating Margin over the range 07/04/2022 - 03/29/2025

SYRS (Syros Pharmaceuticals): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
Comprehensive company analysis:Syros Pharmaceuticals Inc., SYRS
Finished products of Syros Pharmaceuticals, Inc

Outsourcing production to CMO facilities minimizes capital expenditures for Syros Pharmaceuticals (SYRS), directly impacting the efficiency of cost management. This operating profit margin is calculated as the ratio of operating income to revenue, allowing investors to assess the commercial profitability of the business excluding debt obligations and taxes, thereby identifying consolidation phases prior to potential market downturns.

Main competitors

Operating Sales Margin TEM|QGEN - Operating Profitability Margin|Operating Margin IONS|RGEN - Operating Return on Sales|Operating Profitability Avidity RNA|Operating Margin CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operating Margin|Ultragenyx Pharma (RARE) - Operating Sales Margin|beamtx.com (BEAM) - Operating Profitability|SRPT: Operating Profit Ratio|Operating Sales Margin TWST|TXG - Operating Profitability Margin|Operating Margin NTLA|Profitability of Operations Stoke Therapeutics|Operating Profitability BioLife Solutions BLFS|Wave Life Sciences (WVE) - Operating Return on Sales|Maze Therapeutics, Inc. - Operating Margin|Profitability of Operations Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operating Profitability|TSHA: Operating Profit Ratio|Operating Profitability uniQure Pharma|MGTX - Operating Profitability Margin|Operating Margin RGNX|Operating Profitability SLDB (Solid Biosciences)|Ocugen Corp - Operating Sales Margin|PACB: Return on Sales by Operating Profit|benitec.com - Operating Margin|DSGN - Operating Margin|RCKT: Operating Margin|FDMT (4D Molecular Therapeutics Inc) - Operating Profitability|Operating Sales Margin LXEO|Operating Profitability KRRO|Operating Margin EDIT|SLN - Operating Return on Sales|Operating Margin PRQR (ProQR)|CDXS - Operating Sales Margin|Sangamo Therapeutics Inc. - Operating Margin|NAUT - Operating Margin|MGX: Operating Margin|Operating Sales Margin Precision BioSciences, Inc.|GBIO (Generation Bio) - Operating Margin|Boundless Bio Inc. (BOLD) - Profitability of Operations|Operating Sales Margin XCUR (exicuretx.com)|Imunon Inc - Return on Sales by Operating Profit|Operating Margin PHIO (Phio Pharmaceuticals Corp)|Operating Profit Rate MBIO|RNAZ - Operating Profitability|Operating Profit Rate BNGO (bionanogenomics.com)|Applied DNA Sciences (APDN) - Operating Profitability|Bluebird Bio - Operating Profit Rate|IPA (ImmunoPrecise Antibodies Ltd) - Operating Margin|Operating Return on Sales Omega Therapeutics, Inc. OMGA|Operating Margin OMIC|RGLS (Regulus Therapeutics Inc.) - Operating Profit Rate|Telesis Bio - Operating Sales Margin|Operating Profit Rate TCON|UBX - Operating Profitability